再生醫學（骨與關節）市場：按技術、應用和地區分類

預計到 2026 年，再生醫學（骨骼和關節）市場規模將達到 103 億美元，到 2033 年將達到 213 億美元。預計從 2026 年到 2033 年，該市場將以 11% 的複合年成長率成長。

再生醫學是一個生物學上多元化的領域，它融合了材料科學、工程、醫學、生物科學和外科手術。它透過增強和刺激人體自身的再生和自癒能力來發揮治療作用。再生醫學致力於開發再生、修復或取代受損或病變細胞、器官和組織的方法。此醫學領域涵蓋幹細胞的生成和利用，以及組織工程。

此外，市場上的主要參與者也致力於拓展自身能力。例如，2020年3月，BioStem Technologies Inc.旗下專注於再生醫學研發的子公司BioStem Life Sciences宣布，將在美國佛羅裡達州的工廠增設一個研發實驗室。

市場動態

專注於再生醫學領域產品核可的領導企業預計將推動全球再生醫學（骨骼和關節）市場的成長。例如，2017年，卡爾舒馬克牙科有限公司推出了一系列新的再生醫學產品，包括同種異體移植片、異質骨移植、合成膜和膠原蛋白膜。

此外，3D列印技術在再生醫學（骨骼和關節）領域的應用有望促進全球再生醫學（骨骼和關節）市場的成長。例如，2020年2月，美國維克森林醫科大學的研究人員報告了將神經細胞整合到生物列印的骨骼肌結構中，以促進體內功能性肌肉再生的研究成果。

此外，關節炎的高發生率預計將在預測期內推動全球再生醫學（骨骼和關節）市場的成長。例如，根據美國疾病管制與預防中心 (CDC) 2019 年 5 月的報告，美國約有 5,440 萬成年人被診斷出患有關節炎，相當於四分之一的美國人。

本研究的主要特點：

• 本報告對全球再生醫學（骨骼和關節）市場進行了詳細分析，包括預測期（2026-2033 年）的市場規模和複合年成長率（%）。
• 本報告揭示了各個細分市場的潛在商機，並說明了該市場極具吸引力的投資提案矩陣。此外，報告還深入分析了市場促進因素、阻礙因素、機會、區域前景以及主要參與者所採取的競爭策略。
• 此外，我們根據以下參數介紹了全球再生醫學（骨骼和關節）市場主要參與者的概況：公司概況、財務績效、產品系列、企業發展區域、主要發展和未來計劃。
• 本報告提供的見解將有助於企業行銷負責人和經營團隊就未來的市場擴張和行銷策略做出明智的決策。
• 這份《全球再生醫學（骨與關節）市場》報告的目標受眾是該行業的眾多相關人員，包括投資者、產品開發商和製造商、經銷商、醫療機構、研究機構、新參與企業和金融分析師。
• 全球再生醫學（骨骼和關節）市場的主要公司包括 Anika Therapeutics, Inc.、Arthrex, Inc.、Baxter International, Inc.、CONMED Corporation、強生公司、美敦力公司、史密斯和內普公司、史賽克公司、Zimmer Holdings, Inc.、Aziyo Biologics 和 Ortho Regenerative Technologies Inc.。
• 相關人員可以透過利用全球再生醫學（骨骼和關節）市場分析中使用的各種策略矩陣進行決策，從而獲得極大的益處。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場概覽

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因子
  • 市場機遇
• 影響分析
• 市場趨勢
• 主要進展
• 按疾病分類的核准情況
• 合作關係、併購
• 監理情勢
• PEST分析
• 波特五力分析
• 流行病學
• 穩健的管道分析

第4章 全球再生醫學（骨與關節）市場：依技術分類，2021-2033年

• 幹細胞
• 生物材料
• 組織工程

第5章 全球再生醫學（骨與關節）市場：依應用領域分類，2021-2033年

• 骨移植替代物
• 骨骼和關節疾病
• 異體骨
• 自體骨
• 其他

第6章 全球再生醫學（骨與關節）市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲國家
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太國家
• 中東
  • GCC
  • 以色列
  • 其他中東國家
• 非洲
  • 北非
  • 中非
  • 南非

第7章 競爭情勢

• 熱圖分析
• 市佔率分析
• 公司簡介
  • Anika Therapeutics, Inc
  • Arthrex, Inc.
  • Baxter International, Inc.
  • CONMED Corporation
  • Johnson & Johnson
  • Medtronic, Plc
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Holdings, Inc.
  • Aziyo Biologics
  • Ortho Regenerative Technologies Inc.
• 分析師意見

第8章

• 參考
• 調查方法
• 關於本公司

Regenerative Medicine (Bone and Joint) Market is estimated to be valued at USD 10.3 Bn in 2026 and is expected to reach USD 21.3 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11% from 2026 to 2033.

Regenerative medicine is a biological heterogeneous domain that incorporates material science, engineering, medicine, biological science, and surgery. It acts therapeutically by augmenting and stimulating the body's capacity for regeneration and self-repair. Regenerative medicine involves the development of methods to regrow, repair or replace either the damaged or diseased cells, organs or tissues. This medicinal branch includes the generation and usage of stem cells and tissue engineering.

Moreover, Major players in the market are also focused on expanding their capabilities. For instance, in March 2020, BioStem Life Sciences, a subsidiary of BioStem Technologies Inc. and a developer of regenerative therapies, announced to add R&D laboratory to its Florida, U.S. facility.

Market Dynamics

Key companies focusing on product approvals in regenerative medicine is expected to drive the global regenerative medicine (Bone and Joint) market growth. For instance, in 2017, Karl Schumacher Dental, LLC launched its new range of regenerative products, which include allograft, xenograft, and synthetic and collagen membranes.

Moreover, adoption of 3D printing technology in regenerative medicine (bone and joint) is expected to aid in growth of the global regenerative medicine (bone and joint) market. For instance, in February 2020, researchers from Wake Forest School of Medicine, U.S. reported investigation of the effects of neural cell integration into the bioprinted skeletal muscle construct to accelerate functional muscle regeneration in vivo.

Furthermore, High prevalence of arthritis is expected to propel growth of the global regenerative medicine (bone and joint) market over the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC)'s May 2019 report, around 54.4 million U.S. adults had diagnosed arthritis, which accounted for around 1 in 4 people in the U.S.

Key features of the study:

• This report provides in-depth analysis of the global regenerative medicine (bone and joint) market, and provides market size (US$ Bn) and compound annual growth rate (CAGR) (%) for the forecast period (2026-2033)
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, regional outlook, and competitive strategies adopted by the leading players.
• It profiles leading players in the global regenerative medicine (bone and joint) market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
• Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansions and marketing tactics
• The global regenerative medicine (bone and joint) market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
• The key players operating in global regenerative medicine (Bone and Joint) market include Anika Therapeutics, Inc, Arthrex, Inc., Baxter International, Inc., CONMED Corporation, Johnson & Johnson, Medtronic, Plc, Smith & Nephew plc, Stryker Corporation, Zimmer Holdings, Inc., Aziyo Biologics, and Ortho Regenerative Technologies Inc.
• Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global regenerative medicine (bone and joint) market

Market Segmentation

• By Technology (Revenue, USD Bn, 2021-2033)
• Stem Cell
• Biomaterial
• Tissue Engineering
• By Application (Revenue, USD Bn, 2021-2033)
• Bone Graft Substitutes
• Osteoarticular Diseases
• Allogeneic Bones
• Autogenic Bones
• Others
• By Region (Revenue, USD Bn, 2021-2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • Central Africa
  • North Africa
• Key Players
• Anika Therapeutics, Inc
• Arthrex, Inc.
• Baxter International, Inc.
• CONMED Corporation
• Johnson & Johnson
• Medtronic, Plc
• Smith & Nephew plc
• Stryker Corporation
• Zimmer Holdings, Inc.
• Aziyo Biologics
• Ortho Regenerative Technologies Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Technology
  • Market Snapshot, By Application
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Disease Type Approval
• Collaboration/Merge/Acquisition
• Regulatory Landscape
• PEST Analysis
• Porter's Five Forces Analysis
• Epidemiology
• Robust Pipeline Analysis

4. Global Regenerative Medicine (Bone and Joint) Market, By Technology, 2021 - 2033, (USD Billion)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022- 2033
  • Segment Trends
• Stem Cell
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
• Biomaterial
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
• Tissue Engineering
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

5. Global Regenerative Medicine (Bone and Joint) Market, By Application, 2021 - 2033, (USD Billion)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022- 2033
  • Segment Trends
• Bone Graft Substitutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
• Osteoarticular Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
• Allogeneic Bones
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
• Autogenic Bones
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Global Regenerative Medicine (Bone and Joint) Market, By Region, 2021 - 2033, (USD Billion)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2022-2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Billion)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis
• Company Profile
  • Anika Therapeutics, Inc
    • Company Highlights
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Market Strategies
  • Arthrex, Inc.
    • Company Highlights
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Market Strategies
  • Baxter International, Inc.
    • Company Highlights
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Market Strategies
  • CONMED Corporation
    • Company Highlights
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Market Strategies
  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Market Strategies
  • Medtronic, Plc
    • Company Highlights
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Market Strategies
  • Smith & Nephew plc
    • Company Highlights
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Market Strategies
  • Stryker Corporation
    • Company Highlights
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Market Strategies
  • Zimmer Holdings, Inc.
    • Company Highlights
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Market Strategies
  • Aziyo Biologics
    • Company Highlights
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Market Strategies
  • Ortho Regenerative Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Market Strategies
• Analyst Views

8. Section

• References
• Research Methodology
• About Us